Entonox clinical trials
How each study uses Entonox is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Entonox studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2007 (3)
| Year | Studies |
|---|---|
| 2007 | 3 |
| 2008 | 1 |
| 2013 | 2 |
| 2019 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 4
Air Liquide Santé International (4) · Rajavithi Hospital (1) · Sheffield Teaching Hospitals NHS Foundation Trust (1) · University of Oxford (1) · The Royal Bournemouth Hospital (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 1 phase 3 study under way
Entonox is the comparator. A study of two new drugs counts under both.
- 1Fentanyl · KK Women's and Children's Hospital
- 1Ropivacaine · KK Women's and Children's Hospital
Studies
Open first, then newest update. How each study uses Entonox is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Nitrous Oxide and EMOtional CognitionRecruitingNot applicableUniversity of OxfordNCT06557642Written as Entonox
- Study of the Efficacy of Kalinox® 170 Bar in Adult OncologyCompletedPhase 4Air Liquide Santé InternationalNCT00646945Written as 50% Oxygen/50% Nitrous oxide premix (Kalinox 170 bar)
- Use of 50% Nitrous Oxide / 50% Oxygen Premix in Primary Care Dental CentersCompletedPhase 3Air Liquide Santé InternationalNCT00643838Written as Kalinox 170 bar
- Use of 50% Nitrous Oxide / 50% Oxygen Premix During Liver Biopsy of Focal LesionCompletedPhase 4Air Liquide Santé InternationalNCT00643656Written as Kalinox 170 bar
- The Effect of Entonox on Stages of Labor in Nulliparous WomenCompletedNot applicableRajavithi HospitalNCT04321642Written as Entonox
- A Single-centre Study of Entonox Versus Midazolam Sedation in GastroscopyTerminatedPhase 4The Royal Bournemouth HospitalNCT01744184Written as Entonox
- Optimizing the Use of Entonox® During Screening ColonoscopyCompletedPhase 4Sheffield Teaching Hospitals NHS Foundation TrustNCT01865721Written as Entonox
- Study of the Efficacy and Safety of Kalinox® 170 Bar for the Performance of Care Procedures in Children With BurnsWithdrawnPhase 3Air Liquide Santé InternationalNCT00643357Written as 50% Oxygen/50% Nitrous oxide premix (KALINOX 170 bar)
As the comparator · 1 — what is tested is compared with Entonox
Codes
What other systems call Entonox · ClinicalTrials.gg INT002229
- MeSH (NLM) C001147EntonoxOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C001147 | Entonox | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.